These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 29517259)

  • 41. Olfactory function is associated with cognitive performance: results from the population-based LIFE-Adult-Study.
    Yahiaoui-Doktor M; Luck T; Riedel-Heller SG; Loeffler M; Wirkner K; Engel C
    Alzheimers Res Ther; 2019 May; 11(1):43. PubMed ID: 31077241
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Practical application of the CERAD test battery as a neuropsychological dementia screening test].
    Satzger W; Hampel H; Padberg F; Bürger K; Nolde T; Ingrassia G; Engel RR
    Nervenarzt; 2001 Mar; 72(3):196-203. PubMed ID: 11268764
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Can the CERAD neuropsychological battery be used to assess cognitive impairment in Parkinson's disease?
    Camargo CHF; Bronzini A; Tolentino ES; Medyk C; Schultz-Pereira GL
    Arq Neuropsiquiatr; 2018 Mar; 76(3):145-149. PubMed ID: 29809231
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mayo normative studies: regression-based normative data for ages 30-91 years with a focus on the Boston Naming Test, Trail Making Test and Category Fluency.
    Karstens AJ; Christianson TJ; Lundt ES; Machulda MM; Mielke MM; Fields JA; Kremers WK; Graff-Radford J; Vemuri P; Jack CR; Knopman DS; Petersen RC; Stricker NH
    J Int Neuropsychol Soc; 2024 May; 30(4):389-401. PubMed ID: 38014536
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characteristics of Mild Cognitive Impairment Using the Thai Version of the Consortium to Establish a Registry for Alzheimer's Disease Tests: A Multivariate and Machine Learning Study.
    Tunvirachaisakul C; Supasitthumrong T; Tangwongchai S; Hemrunroj S; Chuchuen P; Tawankanjanachot I; Likitchareon Y; Phanthumchinda K; Sriswasdi S; Maes M
    Dement Geriatr Cogn Disord; 2018; 45(1-2):38-48. PubMed ID: 29617684
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Linear and Nonlinear Effect of Years of Schooling, Sex, and Age on the CERAD-MX and Complementary Tasks in a Mexican Sample: A Cross-Sectional Study.
    Zuno Reyes A; Trejo S; Matute E
    Arch Clin Neuropsychol; 2023 Aug; 38(6):962-975. PubMed ID: 36747327
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Performance of elderly African American and White community residents on the CERAD Neuropsychological Battery.
    Fillenbaum GG; Heyman A; Huber MS; Ganguli M; Unverzagt FW
    J Int Neuropsychol Soc; 2001 May; 7(4):502-9. PubMed ID: 11396552
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Age, education and test performance on the Finnish CERAD.
    Karrasch M; Laine M
    Acta Neurol Scand; 2003 Aug; 108(2):97-101. PubMed ID: 12859285
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Demographically Corrected Normative Z Scores on the Neuropsychological Test Battery in Cognitively Normal Older Chinese Adults.
    Ruan Q; Xiao F; Gong K; Zhang W; Zhang M; Ruan J; Zhang X; Chen Q; Yu Z
    Dement Geriatr Cogn Disord; 2020; 49(4):375-383. PubMed ID: 33176318
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early detection of Alzheimer's disease with a total score of the German CERAD.
    Ehrensperger MM; Berres M; Taylor KI; Monsch AU
    J Int Neuropsychol Soc; 2010 Sep; 16(5):910-20. PubMed ID: 20682088
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of educational background on verbal fluency task performance in older adults with Alzheimer's disease and mild cognitive impairment.
    Kawano N; Umegaki H; Suzuki Y; Yamamoto S; Mogi N; Iguchi A
    Int Psychogeriatr; 2010 Sep; 22(6):995-1002. PubMed ID: 20602860
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Attention and CERAD test performances in cognitively impaired elderly subjects.
    Verhülsdonk S; Hellen F; Höft B; Supprian T; Lange-Asschenfeldt C
    Acta Neurol Scand; 2015 Jun; 131(6):364-71. PubMed ID: 25352352
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Robust norms for neuropsychological tests of verbal episodic memory in Australian women.
    Goodwill AM; Campbell S; Henderson VW; Gorelik A; Dennerstein L; McClung M; Szoeke C
    Neuropsychology; 2019 May; 33(4):581-595. PubMed ID: 30829514
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Population normative data for the 10/66 Dementia Research Group cognitive test battery from Latin America, India and China: a cross-sectional survey.
    Sosa AL; Albanese E; Prince M; Acosta D; Ferri CP; Guerra M; Huang Y; Jacob KS; de Rodriguez JL; Salas A; Yang F; Gaona C; Joteeshwaran A; Rodriguez G; de la Torre GR; Williams JD; Stewart R
    BMC Neurol; 2009 Aug; 9():48. PubMed ID: 19709405
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Handgrip strength is associated with learning and verbal fluency in older men without dementia: insights from the NHANES.
    Prokopidis K; Giannos P; Ispoglou T; Kirk B; Witard OC; Dionyssiotis Y; Scott D; Macpherson H; Duque G; Isanejad M
    Geroscience; 2023 Apr; 45(2):1049-1058. PubMed ID: 36449219
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuropsychological test norms controlled for physical health: does it matter?
    Bergman I; Almkvist O
    Scand J Psychol; 2015 Apr; 56(2):140-50. PubMed ID: 25356656
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Frontotemporal dementia: patient characteristics, cognition, and behaviour.
    Diehl J; Kurz A
    Int J Geriatr Psychiatry; 2002 Oct; 17(10):914-8. PubMed ID: 12325050
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The CERAD neuropsychological assessment battery total score detects and predicts Alzheimer disease dementia with high diagnostic accuracy.
    Wolfsgruber S; Jessen F; Wiese B; Stein J; Bickel H; Mösch E; Weyerer S; Werle J; Pentzek M; Fuchs A; Köhler M; Bachmann C; Riedel-Heller SG; Scherer M; Maier W; Wagner M;
    Am J Geriatr Psychiatry; 2014 Oct; 22(10):1017-28. PubMed ID: 23759289
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CERAD neuropsychological battery total score in multinational mild cognitive impairment and control populations: the AddNeuroMed study.
    Paajanen T; Hänninen T; Tunnard C; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H; Addneuromed Consortium
    J Alzheimers Dis; 2010; 22(4):1089-97. PubMed ID: 20930314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.